Acain, Sam Emeric B.

HRN: 28-56-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
02/25/2026
03/05/2026
PO
7.5ml
Q8H
S/P OR Plating Both Femur
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: